Patents by Inventor Timothy Ritchie

Timothy Ritchie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LACTATE ENHANCING COMPOUNDS AND USES THEREOF
    Publication number: 20260125357
    Abstract: The present invention relates to new agents useful for stimulating uptake of glucose and release of lactate by astrocytes. The invention further relates to methods of preparation, formulations and therapeutic uses of those agents, notably for the prevention and/or treatment of neurological disorders with brain energy hypometabolism, in particular neurodegenerative, neurometabolic and psychiatric disorders or improving cognitive and memory functions.
    Type: Application
    Filed: October 2, 2023
    Publication date: May 7, 2026
    Inventors: CHARLES FINSTERWALD, SYLVAIN LENGACHER, PIERRE MAGISTRETTI, TIMOTHY RITCHIE, HANS MAAG, GUILLAUME DUVEY
  • Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
    Publication number: 20070249617
    Abstract: The present invention relates to 1-aza-bicycloalkyl derivatives of formula I, wherein X is CH2 or a single bond; Y is a group of formula and wherein R has the meanings as defined in the specification, which compounds are alpha 7 nicotinic acetylcholine receptor (nAChR) agonists; to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
    Type: Application
    Filed: June 26, 2007
    Publication date: October 25, 2007
    Inventors: Dominik Feuerbach, Konstanze Hurth, Timothy Ritchie
  • Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
    Publication number: 20060167002
    Abstract: The present invention relates to 1-aza-bicycloalkyl derivatives of formula (I), wherein X is CH2 or a single bond; Y is a group of formula (II, III, IV) and wherein R has the meanings as defined in the specification, which compounds are alpha 7 nicotinic acetylcholine receptor (nAChR) agonists; to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.
    Type: Application
    Filed: September 3, 2003
    Publication date: July 27, 2006
    Inventors: Dominik Feuerbach, Konstanze Hurth, Timothy Ritchie